MetaADEDB 2.0 @ LMMD
safinamide
(NEMGRZFTLSKBAP-LBPRGKRZSA-N)
Structure
SMILES
NC(=O)[C@@H](NCc1ccc(cc1)OCc1cccc(c1)F)C
Type(s)
Approved; Investigational
ATC code(s)
N04BD03
Molecular Formula:
C17H19FN2O2
Molecular Weight:
302.343
Log P:
3.4593
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
64.35
CAS Number(s):
133865-89-1
Synonym(s)
1.
safinamide
2.
(S)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide
3.
2-(4-(3-fluorobenzyloxy)benzylamino)propionamide
4.
FCE 26743
5.
FCE 28073
6.
FCE-26743
7.
FCE-28073
8.
NW-1015
9.
PNU 151774E
10.
PNU-151774E
11.
fbap methanesulfonate
12.
safinamide methanesulfonate
External Link(s)
MeSHC092797
PubChem Compound131682
BindingDB50078694
19187
ChEBI134718
CHEMBLCHEMBL396778
DrugBankDB06654
DrugCentral4921
IUPHAR/BPS Guide to PHARMACOLOGY8291
KEGGdr:D10158
Therapeutic Target DatabaseD02MOK
D0TV6I
ZINC53084692
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 3US FAERS
2Abdominal PainFAERS: 1US FAERS
3Acute myocardial infarctionFAERS: 1US FAERS
4AtaxiaFAERS: 1US FAERS
5ErythemaFAERS: 1US FAERS
6Feeling abnormalFAERS: 1US FAERS
7LeukopeniaFAERS: 1US FAERS
8Myocardial InfarctionFAERS: 1US FAERS
9Myocardial ruptureFAERS: 1US FAERS
10Oral painFAERS: 1US FAERS
11Oromandibular dystoniaFAERS: 1US FAERS
12PancreatitisFAERS: 1US FAERS
13Peripheral swellingFAERS: 1US FAERS
14RestlessnessFAERS: 1US FAERS
15SunburnFAERS: 1US FAERS
16TachyarrhythmiaFAERS: 1US FAERS
17ThrombocytopeniaFAERS: 1US FAERS
18Parkinson Disease21777011CTD
19Parkinsonian Disorders22017497CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.